phosphorylethanolamine has been researched along with Cognition Disorders in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, R | 1 |
| Tkac, I | 1 |
| Unger, EL | 1 |
| Ennis, K | 1 |
| Hurst, A | 1 |
| Schallert, T | 1 |
| Connor, J | 1 |
| Felt, B | 1 |
| Georgieff, MK | 1 |
1 other study available for phosphorylethanolamine and Cognition Disorders
| Article | Year |
|---|---|
Iron supplementation dose for perinatal iron deficiency differentially alters the neurochemistry of the frontal cortex and hippocampus in adult rats.
Topics: Anemia, Iron-Deficiency; Animals; Aspartic Acid; Cognition Disorders; Dietary Supplements; Dipeptide | 2013 |